Pegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremia

Wedemeyer H., Yurdaydin C., Zachou K., Erhardt A., Drebber U., Cakaloglu Y., ...More

57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 27 - 31 October 2006, vol.44 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 44
  • City: Massachusetts
  • Country: United States Of America
  • Istanbul University Affiliated: No